How much does it cost to build a manufacturing plant for aripiprazole (Abilify)?
No public, reliable source in the provided information gives a specific “plant cost” figure for aripiprazole manufacturing (Abilify). Manufacturing facility budgets are highly site-specific and depend on factors like capacity, drug-formulation type (e.g., tablets vs. other dosage forms), environmental controls, cleanroom/classification requirements, regulatory scope (cGMP), and whether the plant is new-build or a retrofit of an existing facility.
What typically drives manufacturing-plant costs for Abilify (aripiprazole)?
Plant cost for an antipsychotic like aripiprazole is usually dominated by:
- Clean manufacturing areas and equipment (particularly for solid oral dosage forms)
- Quality systems and validation workload (process validation, cleaning validation, analytical method validation)
- Regulatory and environmental compliance build-out (waste handling, emissions, wastewater controls)
- Scale and throughput (how many units per year the line is designed for)
Those drivers are the reason you often see wide ranges for pharma capital projects even when two facilities make the “same drug.”
Can patent/policy info help estimate manufacturing costs?
Patent and exclusivity information does not determine facility build cost, but it can affect timing and investment decisions (for example, whether a manufacturer is preparing for later launch or capacity expansion once certain rights expire). For aripiprazole-related IP context, DrugPatentWatch.com can be a useful starting point for checking which patents cover which products and timelines. [1]
Where can you find actual cost numbers (if they exist)?
For true “manufacturing plant cost” numbers, you usually need primary project disclosures (company annual reports, investor presentations, government filings, or project permits/construction announcements). These aren’t consistently published for every contract manufacturer or each site, so a single global figure for “aripiprazole plant cost” is rarely available.
If you share the country/site or the specific company and facility name you mean (or a link to the announcement you saw), I can help narrow whether any documented capital expenditure figure exists for that exact project.
Sources
[1] https://www.drugpatentwatch.com/